MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Identifying healthy Parkin mutation carriers based on sensor-based posturography and gait analysis

    J. Prasuhn, M. Borsche, A. Hicks, M. Gögele, C. Egger, C. Kritzinger, L. Langlott, M. Kasten, C. Klein, P. Pramstaller, N. Brüggemann (Lübeck, Germany)

    Objective: To discriminate healthy Parkin mutation carriers from healthy non-mutation carriers using sensor-based motion analysis. Background: Identifying endophenotypes for PD is crucial for testing potential…
  • 2019 International Congress

    Acute Onset Parkinsonism Secondary to West Nile Virus Encephalitis

    M. Purbaugh, F. Ali, T. Diesing, A. Hellman (Omaha, NE, USA)

    Objective: To demonstrate a case of acute Parkinsonism caused by West Nile Virus (WNV) Encephalitis that improved with resolution of the infection. Background: Acute onset…
  • 2019 International Congress

    A general impaired-rhythm system underpins oro-motor, manual, and gait rhythmic disturbances in Parkinson’s disease

    F. Puyjarinet, V. Bégel, C. Gény, V. de Cock, V. Driss, M. Cuartero, S. Pinto, S. Dalla Bella (Montpellier, France)

    Objective: To assess whether rhythmic disturbances in three different domains (i.e., oro-motor, finger tapping and gait domains) are related in Parkinson's disease (PD), and to…
  • 2019 International Congress

    Braak model in Parkinson disease using MRI biomarkers

    N. Pyatigorskaya, L. Yahia-Cherif, R. Valabregue, R. Gaurav, M. Mongin, C. Ewenczyk, C. Gallea, F. Gargouri, E. Bardinet, I. Arnulf, M. Vidailhet, S. Lehericy (Paris, France)

    Objective: The aim of this study was to test using multimodal MRI biomarkers if the pattern of neurodegeneration in the brain of patients with PD…
  • 2019 International Congress

    Improving neuroprotective effects of resveratrol by brain targeting through chitosan glutamate nanoparticles in MPTP induced parkinsonism

    M-R. Rahman, V-K. Kumar (Allahabad, India)

    Objective: The aim of the present study was to develop and evaluate the neuroprotective effects of resveratrol (RV) using chitosan glutamate nanoparticles (RV-CG-NPs) in a…
  • 2019 International Congress

    Apigenin loaded Phospholipid based nanoemulsion in Therapeutics of Parkinson’s Disease Via Attenuation of Oxidative Stress and Upregulation of Dopamine.

    M-R. Rahman, V-K. Kumar (Allahabad, India)

    Objective: The aim of the present study was to develop, optimizes and evaluate the antiparkinson effects of apigenin loaded phospholipid based nanoemulsion via attenuation of…
  • 2019 International Congress

    Cognitive impairment in patients with Parkinson’s syndrome

    SH. Rakhimova, I. Usmonaliev, Y. Musaeva (Tashkent, Uzbekistan)

    Objective: Study the principle of cognitive impairment in Parkinson's syndrome (brain cerebral circulation disorder, backdrop of atherosclerosis). Background: Parkinsonism-neurologic syndrome is a disorderly degenerative disease…
  • 2019 International Congress

    Retinal thickness and microvascular pattern in early Parkinson’s disease.

    C. Rascunà, C. Terravecchia, A. Russo, G. Mostile, CE. Cicero, A. Luca, N. Castellino, A. Longo, T. Avitabile, M. Reibaldi, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: To detect changes in retinal thickness and their possible correlates with microvascular pattern in early PD patients as compared to controls. Background: Physiologically, retinal…
  • 2019 International Congress

    Risk of Parkinson’s in idiopathic anosmia

    R. Rees, S. Gane, C. Philpott, A. Noyce, A. Schrag (Norwich, United Kingdom)

    Objective: To identify markers of increased risk of Parkinson’s in a cohort of individuals with idiopathic anosmia Background: Smell loss (anosmia) is a common finding…
  • 2019 International Congress

    The contribution of cerebrovascular risk factors, metabolic and inflammatory changes to cognitive decline in Parkinson’s disease

    I. Rektor, B. Vesely, N. Bohnen, E. Koritakova, E. Kurca, P. Valkovic (Brno, Czech Republic)

    Objective: To examine the contributions of systemic factors to clinically relevant cognitive decline in Parkinson’s disease (PD), we studied the impact of cardiometabolic and inflammatory…
  • « Previous Page
  • 1
  • …
  • 1295
  • 1296
  • 1297
  • 1298
  • 1299
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley